Global Omega-3 Market By Type (ALA, EPA, and DHA), By Source (Marine and Plants), By Application (Dietary Supplements, Functional/Fortified Foods, Infant Formulae, Pharmaceuticals, Animal Feed, and Pet Food), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 21710
- Number of Pages: 385
- Format:
- keyboard_arrow_up
Quick Navigation
Report Overview
The Global Omega-3 Market size is expected to be worth around USD 2,682 Million by 2032 from USD 1,698 Million in 2022, growing at a CAGR of 4.80% during the forecast period from 2023 to 2032.
Omega-3 is the healthy fats that support health benefits to the body. Most of the users in North America and Europe desire krill oil rather than other traditional bases of fish oil due to its unpleasant flavor, acid influx, and large capsules.
It is attributable to the rising use of omega-3-based constituents in the daily diet to support brain and heart health. It is also projected that increasing consumer spending on healthcare and well-being will increase product demand.
As consumers look for alternatives to conventional fish oil, the request’s product offerings continue to diversify. Krill oil is one of the most significantly used sources of omega-3 due to its health properties compared to regular fish oil. Similar factors will show significant Omega-3 demand during the forecast period.
Key Takeaways
- Market Growth and Size: The global Omega-3 market is expected to reach approximately USD 2,682 million by 2032, with a compound annual growth rate (CAGR) of 4.80%. This represents significant growth from USD 1,698 million in 2022.
- Omega-3 Overview: Omega-3 is a type of healthy fat known for its various health benefits, particularly for heart and brain health. Consumers in North America and Europe prefer krill oil over traditional fish oil due to its superior properties.
- Driving Factors Positive health benefits of Omega-3, such as its use in functional foods, nutritional supplements, and pharmaceuticals, have increased demand. The use of Omega-3 in medicines is on the rise, further boosting the market.
- Restraining Factors: Increased pollutants in fish, coupled with uneven catches and environmental concerns, are limiting the growth of the fish-based Omega-3 market.
- Growth Opportunities: Omega-3 is increasingly being used in healthcare-related industries, including pet food and pharmaceuticals. Advanced technology is improving the absorption rate of Omega-3, making it more effective.
- Type Analysis: DHA (docosahexaenoic acid) is the most abundant Omega-3 fatty acid and is widely used in dietary supplements and fortified foods. EPA (eicosapentaenoic acid) is also in demand for its various health benefits.
- Source Analysis: Marine sources of Omega-3 dominate the market due to the high content of DHA and EPA found in fish, algae, and marine crustaceans. Plant sources of Omega-3 are expected to grow due to increasing demand for vegetable oils rich in Omega-3 fatty acids.
- Application of Omega-3: Dietary supplements are the primary driver of the Omega-3 market due to their benefits for heart and mental health. Infant formulae and functional/fortified foods are also experiencing growth as Omega-3 is increasingly incorporated.
- Regional Analysis: North America leads the market with a 37.1% revenue share in 2022, driven by the presence of major pharmaceutical companies and growing consumption of Omega-3 in various forms. The Asia-Pacific region is experiencing increased demand, especially in countries like India, China, and Japan, due to the importance of Omega-3 in children’s health.
- Key Players: Several prominent players dominate the Omega-3 market, including DSM, BASF SE, Lonza Group, Glanbia Plc, and others. Manufacturers are focusing on product innovation and expanding production capacity.
Driving Factors
Positive Health Benefits of Omega-3
The recent discovery of the beneficial health effects of polyunsaturated fatty acids (PUFAs) has created a lot of demand. It is used in various applications, such as functional foods, nutritional supplements, and pharmaceuticals.
Growing awareness of the benefits of omega-3 fatty acids as a result of essential fatty acids has increased the demand for long-chain PUFAs.
Increasing Use of Omega-3 in Medicines Boosting the Market Growth
An increasing number of market players using omega-3-related medicines is expected to boost market growth due to expanding product coverage of drugs.
Factors such as increasing adoption of omega-3-based products in pet food and pharmaceuticals, increasing disposable income, and increasing public initiatives related to health and well-being are also expected to drive market growth further.
High Bioavailability and Absorption Rate
One of the key factors driving the growth of the omega-3 market is the advanced technological advancements that increase the body’s ability to supply and absorb these substances. The production of lipid-based supplements remains demanding due to their unpredictable bioavailability and absorption rates. In addition, advances in processing techniques demonstrate that the extraction of omega-3 from new sources will drive demand for the product.
Rising Health Awareness of Omega-3
Omega-3 fatty acids help reduce the risk of abnormal heart rhythms or arrhythmias, which can lead to the patient’s sudden death. It also helps reduce triglyceride levels, slows the growth of atherosclerotic plaques, and lowers blood pressure.
Consumers are increasingly turning to healthier alternatives while viewing preventive care as an essential tool to help them lead healthier lives. As a result, omega-3s are becoming increasingly popular as they are a rich source of vitamins, proteins, and minerals and can help fight diseases like cancer, asthma, and depression.
Restraining Factors
Increased Pollutant Content in Fish Makes Them Toxic
Uneven catches and increasing demand for fish from other application sources are reducing the availability of fish at low cost and limiting the market growth. Increased environmental, metal, and pollutant content in fish is expected to make them toxic to consume and restrict the development of the segment.
In addition, they are tightening regulations on fishing activities to protect fish species. It is expected to affect the supply of raw materials for the industry.
Growth Opportunities
Increased Use of Omega-3 in Healthcare-Related Industries Creates Opportunities in the Market
Increased use of omega-3 fatty acids in pet food and pharmaceuticals is driving demand. Growing health and fitness-related public initiatives continue to support the market, driving the need for innovation to remain competitive. Order from consumers due to health benefits will create more market opportunities.
On the other hand, this technology delivers lotions with micro-emulsified formulations designed to improve surface absorption. Omega-3 technology helps emulsify the ointment in the intestine rather than forming a layer on the surface of the gastric juices, significantly reducing the contact area between oil and air. It also helps reduce triglyceride levels, slows the growth of atherosclerotic plaques, and lowers blood pressure.
Omega-3 fatty acids help decrease the risk of anomalous heart rhythms, which can lead to the patient’s unexpected death. Customers are gradually turning to healthier alternatives while viewing protective caution as an essential means to help them lead healthier lives.
As a consequence, omega-3s are becoming increasingly popular as they are a rich source of vitamins, proteins, and minerals and can help fight syndromes like cancer, asthma, and depression.
Trending Factors
Manufacturers Focusing on Product Innovation
Manufacturers are now more inclined toward raw material procurement at competitive pricing. Raw material procurement involves engaging in long-term supply contracts with raw material suppliers.
Some independent manufacturers hire third-party suppliers to sell their products. Omega-3 manufacturers are increasingly focused on product innovation and differentiation as they are steadily moving toward consolidation through mergers & acquisitions, joint ventures, and collaborative partnerships.
Such trends are currently being witnessed in this market, bolstering the demand for these products.
Type Analysis
DHA is the Most Abundant Omega-3
Based on type, Omega-3 was performed into ALA, EPA, and DHA. The docosahexaenoic acid (DHA) form dominated the market in 2022 with the highest sales share. In addition, DHA is widely used in dietary supplements and fortified foods.
It is also used to treat dementia, attention deficit hyperactivity disorder, coronary heart disease (CAD), and type 2 diabetes. The health and medical benefits of DHA are also used in nutritional products for the elderly.
Demand for eicosapentaenoic acid (EPA) will be predicted to grow globally during the forecast period due to its multiple health benefits, such as the prevention of coronary heart disease, hypertension, inflammation, and excess fat.
It is also used to treat diabetes, treat side effects associated with chemotherapy, and recover from surgery. As the most abundant omega-3 fatty acid in the human diet, DHA plays a crucial role. In order for a child’s brain to develop and mature properly, they need DHA.
Source Analysis
Marine Omega-3 Section Dominates the Market
By source, omega-3 is segmented into marine omega-3 and plant omega-3. The marine section holds the largest share in the market with the top profit share in 2022. This is due to the great quantity of DHA and EPA in marine microbes such as fish carcasses or cod liver oil, fatty fish, and algae. Marine crustaceans, comprising krill, are sources rich in omega-3s for human feeding: salmon, pollack, tuna, and mackerel.
The use of marine omega-3 in healthcare is significant. Natural inflammatory conditions involve numerous cell types, chemical intermediaries, and relationships. Omega-3 acids can be used to partially inhibit a variety of inflammatory processes, such as leukocyte chemotaxis, and adhesion molecule expression.
The segment for plant sources is anticipated to expand over the course of the forecast period due to an increase in demand for vegetable oils, which are primarily made from sources like soybean, safflower, sunflower, cotton, and corn seeds, which are rich in omega-3 fatty acids. The environmental benefits of plant sources over fish oil will drive the market in the forecast period.
By Application
Use of Omega-3 in Dietary Supplements Driving the Market
Based on application Omega-3 is classified into dietary Supplements, functional/fortified foods, infant formulae, pharmaceuticals, animal feed, and pet food. Omega-3 in dietary supplements is the primary factor driving the market.
The health effects of omega-3 that support heart and mental health have increased the demand for omega-3 in nutritional supplements.
Personalized nutrition and health have enabled consumers to measure the EPA and DHA amounts in their blood independently. The increasing incorporation of omega-3 products in infant formulae also creates market trends.
Functional or fortified foods have fast-growing applications in the market. Consumers in developed countries like North America and Europe mainly focus on health management. Furthermore, increasing awareness about the benefits of omega-3 for animals and pets is expected to boost the market.
Key Market Segments
Based on Type
- Ala
- EPA
- DHA
Based on Source
- Marine
- Plant
Based on Application
- Dietary Supplements
- Functional/Fortified Foods
- Infant Formulae
- Pharmaceuticals
- Animal Feed
- Pet Food
Regional Analysis
North America Shows a Lucrative Market Share Due to the Presence of Omega-3 Manufacturers Companies
North America dominated the market with the highest revenue share of 37.1% in 2022. It is due to the presence of well-known manufacturers of omega-3-based medicines. The presence of major pharmaceutical companies such as Pfizer, Johnson & Johnson, Amway, and Amarin Pharma also drives demand in the region.
Increasing consumption of omega-3 in the pharmaceutical industry and increased research and development activities related to the product are expected to drive the growth of the North American market during the forecast period.
In addition, athletes’ increased consumption of omega-3-rich nutritional supplements and functional foods is expected to increase market share over the forecast period due to their ability to improve protein synthesis, enhance muscle health and enhance the physical performance of consumers. It is expected to accelerate growth further.
The Asia-Pacific region will see increased demand for packaged baby food as increased participation of women in the workplace is expected to boost demand for infant formula in countries such as India, China, Japan, Australia, and Thailand.
Additionally, it is expected to grow to the increasing importance of omega-3 DHA in children’s nervous systems, vision, and brain development. The ability of products to support long-term health is expected to drive market growth in the coming years.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
Increased intake of omega-3s in numerous uses, growing awareness of healthiness and chronic illnesses, and regulations favoring omega-3s in infant formulas have forced manufacturers to meet customer demand.
The market is witnessing an increasing number of new applicants across the value chain due to increased incomes and enormous market prospects for producers.
The global market is associated, with several prominent players holding majority shares. For example, DSM’s acquisitions of Ocean Nutrition Canada and Marek Biosciences have made DSM one of the world’s major providers of omega-3 materials.
In addition, major companies such as Aker Biomarine Antarctic AS are focusing on expanding production capacity by launching new fishing vessels and increasing product, which will be reproduced in the company’s 2022 sales figures.
To support Antarctic krill harvesting, governments in developing regions have taken numerous advantages to fund research and create innovation alliances that can drive industry growth.
Market Key Players
- Koninklijke DSM N.V.
- BASF SE
- Lonza Group
- Glanbia Plc
- ADM Company
- Farbest Brands
- SternVitamin GmbH & Co. KG
- Adisseo
- BTSA Biotechnologias Aplicadas S.L.
- Rabar Pty Ltd
- Golden Omega
- Kinomega Biopharm Inc.
- Sinomega Biotech Engineering Co. Ltd.
- Pharma Marine AS
- Huatai Biopharm
- ALGISYS LLC
- Biosearch Life
- Other Key Players
Recent Developments
- In November 2022, a DHA starter kit and Algal Omega-3 supplement were introduced in the market by Orlo Nutrition which has a significant positive effect on support systems like the brain, heart, joints, and body.
- In July 2021, Coromega, a Quadra Ingredient Company, launched its first Omega-3 liquid squeeze supplements for dogs.
Report Scope
Report Features Description Market Value (2022) USD 1,698 Mn Forecast Revenue (2032) USD 2,682 Mn CAGR (2023-2032) 4.8% Base Year for Estimation 2022 Historic Period 2016-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Type- ALA, EPA, and DHA; By Source- Marine and Plant; By Application- Dietary Supplements, Functional/Fortified Foods, Infant Formulae, Pharmaceuticals, Animal Feed, and Pet Food Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; the Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape DSM, BASF SE, Lonza Group, Glanbia Plc, ADM, Farbest Brands, SternVitamin GmbH & Co. KG, Adisseo, BTSA Biotechnologies Aplicadas S.L., Rabar Pty Ltd, Golden Omega, Kinomega Biopharm Inc., Sinomega Biotech Engineering Co. Ltd, Pharma Marine AS, Huatai Biopharm, ALGISYS LLC, Biosearch Life, and Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Frequently Asked Questions (FAQ)
How big is the omega-3 market?The global omega-3 market size was estimated at USD 1.6 billion in 2022 and is expected to reach USD 2.6 billion in 2032.
What is the omega-3 market growth?The global omega-3 market is expected to grow at a compound annual growth rate of 4.8% from 2023 to 2032 to reach USD 2.6 billion by 2032.
What are some restraints for global omega-3 market growth?Complexities in extraction and final processing are hampering global omega-3 market growth.
Which is the leading segment in the omega-3 fatty acids market based on the source?The omega-3 concentrates segment is expected to be the leading segment based on the source in the global market during the forecast period.
- Koninklijke DSM N.V.
- BASF SE Company Profile
- Lonza Group AG Company Profile
- Glanbia Plc
- ADM Company
- Farbest Brands
- SternVitamin GmbH & Co. KG
- Adisseo
- BTSA Biotechnologias Aplicadas S.L.
- Rabar Pty Ltd
- Golden Omega
- Kinomega Biopharm Inc.
- Sinomega Biotech Engineering Co. Ltd.
- Pharma Marine AS
- Huatai Biopharm
- ALGISYS LLC
- Biosearch Life
- Other Key Players
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |